UK Startup Funding Report: £877.6m raised across Healthtech, Biotech and AI (12–16 Oct 2026).
It's Friday, 16 October, and this is your UK Startup Funding Report.
A busy week for UK startups saw major rounds across healthtech, biotech and AI, with several large clinical and strategic financings alongside numerous early-stage raises. The market raised a total of £877.6M between 12–16 Oct 2026.
Healthtech & Biotech: funding sustains the clinical pipeline
Clinical devices, diagnostics and drug‑development platforms dominated the week, underlining sustained capital for UK health R&D and for firms seeking commercial scale‑up. Large strategic medtech deals sat alongside late‑stage biotech rounds, a mix that keeps projects moving from lab to patient and gives companies runway to meet regulatory and market milestones.
Notable raises reflected that balance. CMR Surgical closed approximately £301.89 million in preferred equity in a deal that pairs its Versius surgical robotics platform with a US strategic partner and includes an exclusive option to acquire the business in future. OMass Therapeutics raised about £233.75 million in a Series C to push OMS1620 into Phase 2 and generate early human data on an SLC15A4 inhibitor for autoimmune disease. Microbiotica secured £36 million to advance its lead microbiome therapy MB310 into Phase 2 for ulcerative colitis, while Sava Technologies took £27 million and named Ascensia as its European commercialisation partner to back a pivotal study and scale a next‑generation glucose microsensor towards market.
Activity was concentrated around Cambridge, Oxford and London, and funding sources blended strategic corporate capital, public backing and venture rounds. It is not yet clear how every firm will phase commercial roll‑outs, but the flows are keeping clinical ambitions funded and manufacturing plans on track.
This week's Healthtech & Biotech deals:
CMR Surgical closed a major preferred equity investment from Stryker worth approximately £301.9m, coupled with an exclusive option for Stryker to acquire the business in future. The deal pairs CMR’s Versius surgical robotics platform with Stryker’s US commercial reach, aiming to accelerate roll‑out in the world’s largest hospital market while keeping product and non‑US commercial control in Cambridge.
Oxford’s OMass Therapeutics raised £233.8m in a Series C to advance OMS1620 into Phase 2 and to generate early human data for an SLC15A4 inhibitor targeting autoimmune disease. The round, led by major life‑sciences investors, underwrites late‑stage clinical work and signals continued heavyweight capital for UK biotech moving into clinical proof of concept.
Microbiotica closed a £36m Series C led by the British Business Bank to move its lead microbiome therapy MB310 into Phase 2 for ulcerative colitis. The round supports a genomics‑driven live‑biotherapeutic approach that could validate an oral route to repairing the gut epithelial barrier.
Sava Technologies raised £27m and appointed Ascensia as its European commercialisation partner to bring a next‑generation glucose microsensor towards market. The funding will support a pivotal clinical study, scale manufacturing and prepare for regulatory approvals that could expand continuous monitoring options.
AI & Machine Learning: governance and creator tools attract capital
Enterprise and creator‑facing AI tooling continued to draw seed and growth capital, with investors favouring applied models for governance, marketing and monetisation. The flow reflects demand for practical systems that help firms manage AI risk while unlocking new creator revenue streams as businesses race to deploy AI at scale and creators professionalise output.
Several rounds underlined that emphasis. Harmonic Security raised about £37.74 million to expand a platform that monitors and controls workforce AI use and to grow engineering and go‑to‑market teams in the US and UK. Symbe closed roughly £4.3 million to scale an AI platform that automates financeable business cases and aims to shorten procurement cycles for B2B deals. Obsero took £908,000 to build tools that help brands track visibility in AI‑driven answers and to develop AI agents for discovery channels. Affinity Labs raised £1.5 million to build creator‑led software brands supported by an AI factory and to expand creator partnerships ahead of US launches.
Investors are backing both governance tools and creator platforms, with raises spanning pre‑seed to Series B. The pattern suggests appetite for companies that either reduce AI compliance friction or directly monetise AI outputs for brands and creators.
This week's AI & Machine Learning deals:
Harmonic Security closed a £37.7m Series B to expand its platform for monitoring and controlling workforce AI use across organisations. The raise will be used to grow engineering and go‑to‑market teams in the US and UK as businesses seek tools that balance productivity with data and compliance risk.
Symbe raised £4.3m in seed funding to scale an AI platform that automates the creation of financeable business cases for B2B sales. The product aims to shorten procurement cycles by standardising ROI calculations and value engineering across enterprise deals.
Obsero raised £908k to build tools that help brands track and improve visibility in AI‑driven answers and recommendations. The seed funding will be used to develop AI agents, expand engineering and accelerate go‑to‑market activity as AI assistants become central discovery channels.
Affinity Labs raised £1.5m to build creator‑led software brands supported by an AI factory that automates product and growth functions. The pre‑seed will expand product, engineering and creator partnerships ahead of planned US launches.
Fintech & Regtech: alternative rails and compliance automation
Payments, open‑banking and compliance automation rounds this week underscored investor interest in alternative rails and tools that speed cross‑border launches. The deals point to a broader push to reduce reliance on card networks and to automate regulatory work for scaling firms.
TrueLayer raised about £20.4 million in a growth round to scale its Pay by Bank product across Europe and accelerate merchant adoption of account‑to‑account payments. Fruga closed £1 million to scale an open banking layer that turns everyday spending into insurance credits, funding product development and partner integrations. Relace took £1.2 million to build a live regulatory management platform that maps rules to a firm’s operating model and tests regulatory posture across jurisdictions.
For merchants and regulated businesses seeking lower cost and faster onboarding, these infrastructure and compliance tools look set to play a growing role in cross‑border expansion strategies.
This week's Fintech & Regtech deals:
TrueLayer raised £20.4m in a growth round led by CDP Venture Capital to scale its Pay by Bank product across Europe. The finance aims to accelerate merchant adoption of account‑to‑account payments as an alternative to card networks and support the company’s cross‑border expansion.
Insurtech Fruga raised £1m to scale an open banking layer that lets customers accrue insurance credits from everyday spending to cut renewal costs. The capital will be used for product development, partner integrations and hiring in early 2027.
Relace closed £1.2m to build a live regulatory management platform that maps applicable rules to a firm’s operating model and tests regulatory posture. The funding will deepen automated coverage for multiple jurisdictions and speed compliance work for regulated firms.
Deeptech & Hardware: capital targets manufacturing‑ready innovations
Investors directed capital this week to infrastructure and industrial deeptech, from silicon photonics for AI datacentres to bio‑based catalysts and pharma process hardware. The pattern reflects focus on physical‑stack bottlenecks where scale manufacturing and unit economics determine competitiveness.
Salience Labs raised £125 million to scale production of silicon photonics optical circuit switches aimed at AI datacentre connectivity and to back volume manufacturing. HydRegen closed a first close of about £6.04 million to commercialise a bio‑based hydrogenation platform, supporting customer expansion and proof of unit economics for a plug‑and‑play biocatalyst. Medcotec secured £2.4 million to commercialise a single‑use powder transfer valve designed to reduce contamination and downtime in pharmaceutical manufacturing.
Across these rounds investors appear intent on companies that can move from prototype to factory output and demonstrate cost savings at scale. Manufacturing readiness is the common thread.
This week's Deeptech & Hardware deals:
Salience Labs raised £125m to scale production of its silicon photonics optical circuit switches aimed at AI datacentre connectivity. The funds will back volume manufacturing and larger‑port products as the company targets the growing need for high‑bandwidth, low‑latency interconnects between GPU clusters.
HydRegen raised a £6m first close of its Series A to commercialise a bio‑based hydrogenation platform aimed at cutting costs and emissions in chemical manufacturing. The funding will support customer expansion and efforts to prove unit economics at scale for a plug‑and‑play biocatalyst.
Medcotec secured £2.4m to commercialise a single‑use powder transfer valve designed to reduce contamination, blockages and costly cleaning downtime in pharmaceutical manufacturing. The funding will underwrite further trials and initial commercial rollout.
Cybersecurity & Information Ops: continuous verification gains support
Startups focused on adversarial testing and information‑environment tooling raised seed capital as organisations seek continuous verification and AI‑era defences. The emphasis is on automation and persistent testing to keep pace with evolving threats and move defenders away from intermittent fixes.
CodeWall emerged from stealth with approximately £3.02 million in pre‑seed funding to scale an autonomous offensive security platform and broaden enterprise coverage. Ghost Shift raised £465,000, a mix of angel capital and matched UKRI R&D funding, to build capabilities for contested information environments and to explore AI techniques such as inverse learning. Both rounds will underwrite R&D and operational capacity for next‑generation defensive tooling.
These raises underline investor appetite for platforms that provide continuous, evidence‑based verification rather than occasional checks, and they highlight the role of public R&D support alongside private capital in this space.
This week's Cybersecurity & Information Ops deals:
CodeWall emerged from stealth with a £3m pre‑seed to scale its autonomous offensive security platform and broaden enterprise coverage. The product automates continuous adversarial testing, giving defenders persistent, evidence‑based attack paths to verify remediation.
Ghost Shift raised £465k — a mix of angel capital and matched UKRI R&D funding — to build capabilities for contested information environments and to explore AI techniques such as inverse learning. The funds will grow operational capacity and support R&D for next‑generation tools.
Other: ecommerce, proptech and mobility seed activity
Smaller early‑stage raises for consumer, property and transport data plays highlighted steady seed activity outside the core verticals. These rounds typically fund pilot programmes, product development and initial commercial traction for local or sectoral propositions, offering a counterpoint to headline megadeals.
Round Group closed a £4 million seed round to accelerate product development and hires as it refines go‑to‑market plans. Nuba raised £320,000 to test a rewards network linking rent payments, residents and local businesses and to fund pilot operator launches. Alchera took £2.7 million to accelerate transport analysis for highways operators and local authorities, shortening investigation times from weeks to same‑day decisions.
Taken together, these deals show continued investor interest in practical, locality‑focused products that can scale through pilots and partnerships. Which ones will expand nationally remains to be seen, but the pipeline for follow‑on rounds appears active.
This week's Other (Ecommerce, Proptech, Mobility) deals:
Round Group closed a £4m seed round, a notable size for early stage ecommerce, though the company disclosed limited detail on investors or product plans. The capital should permit accelerated product development, hires and early commercial traction as the team clarifies its go‑to‑market strategy.
Nuba raised £320k to build a rewards network linking rent payments, residents and local businesses, using rent as a starting point for a location‑centred membership. The cash will fund pilot operator launches and expansion of rewards partnerships.
Alchera raised £2.7 million in a round.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.